Cargando…
When Hepatitis B Virus Meets Interferons
Chronic hepatitis B virus (HBV) infection imposes a severe burden on global public health. Currently, there are no curative therapies for millions of chronic HBV-infected patients (Lok et al., 2017). Interferon (IFN; including pegylated IFN) is an approved anti-HBV drug that not only exerts direct a...
Autores principales: | Tan, Guangyun, Song, Hongxiao, Xu, Fengchao, Cheng, Genhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058040/ https://www.ncbi.nlm.nih.gov/pubmed/30072974 http://dx.doi.org/10.3389/fmicb.2018.01611 |
Ejemplares similares
-
NF-κB-Dependent IFIT3 Induction by HBx Promotes Hepatitis B Virus Replication
por: Xu, Fengchao, et al.
Publicado: (2019) -
When does hepatitis B virus meet long-stranded noncoding RNAs?
por: Lei, Bingxin, et al.
Publicado: (2022) -
Hepatitis B virus X protein and its host partners
por: Song, Hongxiao, et al.
Publicado: (2021) -
Type III interferon-induced CBFβ inhibits HBV replication by hijacking HBx
por: Xu, Fengchao, et al.
Publicado: (2018) -
Identification of TRIM14 as a Type I IFN-Stimulated Gene Controlling Hepatitis B Virus Replication by Targeting HBx
por: Tan, Guangyun, et al.
Publicado: (2018)